Drug
Apraclonidine Hydrochloride Ophthalmic
Apraclonidine Hydrochloride Ophthalmic: highest development phase Phase 3, developed by Alcon Research. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Alcon Research
Trials
| Drug | Phase | Indication |
|---|---|---|
| Apraclonidine Hydrochloride Ophthalmic Solution NCT06444529 | Phase 3 | Ocular Redness |
| Apraclonidine Hydrochloride Ophthalmic Solution NCT06538662 | Phase 3 | Ocular Redness |
Latest
No recent events.
Follow Apraclonidine Hydrochloride Ophthalmic on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.